key: cord-0887951-9gpxcm7k authors: McCabe, Ruth; Kont, Mara D; Schmit, Nora; Whittaker, Charles; Løchen, Alessandra; Baguelin, Marc; Knock, Edward; Whittles, Lilith K; Lees, John; Brazeau, Nicholas F; Walker, Patrick G T; Ghani, Azra C; Ferguson, Neil M; White, Peter J; Donnelly, Christl A; Hauck, Katharina; Watson, Oliver J title: Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries date: 2021-04-09 journal: Int J Epidemiol DOI: 10.1093/ije/dyab034 sha: c980e8a6c9b3d7183007811cde4ad97ae71e3640 doc_id: 887951 cord_uid: 9gpxcm7k BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has placed enormous strain on intensive care units (ICUs) in Europe. Ensuring access to care, irrespective of COVID-19 status, in winter 2020–2021 is essential. METHODS: An integrated model of hospital capacity planning and epidemiological projections of COVID-19 patients is used to estimate the demand for and resultant spare capacity of ICU beds, staff and ventilators under different epidemic scenarios in France, Germany and Italy across the 2020–2021 winter period. The effect of implementing lockdowns triggered by different numbers of COVID-19 patients in ICUs under varying levels of effectiveness is examined, using a ‘dual-demand’ (COVID-19 and non-COVID-19) patient model. RESULTS: Without sufficient mitigation, we estimate that COVID-19 ICU patient numbers will exceed those seen in the first peak, resulting in substantial capacity deficits, with beds being consistently found to be the most constrained resource. Reactive lockdowns could lead to large improvements in ICU capacity during the winter season, with pressure being most effectively alleviated when lockdown is triggered early and sustained under a higher level of suppression. The success of such interventions also depends on baseline bed numbers and average non-COVID-19 patient occupancy. CONCLUSION: Reductions in capacity deficits under different scenarios must be weighed against the feasibility and drawbacks of further lockdowns. Careful, continuous decision-making by national policymakers will be required across the winter period 2020–2021. National healthcare systems are under extreme pressure due to the coronavirus disease 2019 (COVID- 19) pandemic. To avoid overwhelming hospitals at the beginning of the pandemic, countries implemented stringent non-pharmaceutical interventions (NPIs) including physical distancing and national lockdowns. Although effective in reducing transmission, the economic and social costs of such interventions cast doubt on their long-term tenability. 1 At the same time, countries increased hospital capacity to treat COVID-19 patients, with the opening of field hospitals, reorganization of health services and the cancellation of elective surgery. Nonetheless, many European countries still reported strains on intensive care unit (ICU) resources owing to a surge in demand. [2] [3] [4] Healthcare demand is generally greatest during winter. 5 Healthcare systems must be prepared to deal with this in addition to likely increases in numbers of COVID-19 patients requiring hospitalization in winter 2020-2021. [6] [7] [8] The number of patients in ICUs will be heavily dependent on population behaviour and the effectiveness of NPIs. However, few studies have linked forecasts of COVID-19 healthcare demand under NPIs to national-level estimates of hospital capacity and utilization (e.g. [9] [10] [11] ). Here, we integrate a hospital capacity framework 12, 13 with epidemiological projections of COVID-19 patients requiring ICU treatment 14 in three European countries that have been heavily affected by the pandemic. We present a scenario-based analysis of the spare capacity of ICU beds, ventilators and staff in France, Germany and Italy over the winter period 2020-2021 under a 'dual-demand' (COVID-19 and non-COVID-19) patient model. We examine the effect of suppression strategies of varying effectiveness that are triggered based on different levels of ICU occupancy by COVID-19 patients. We estimate the spare capacity, defined as the difference between the number of patients that can be accommodated in the ICU and the number of patients requiring ICU care, of four essential resources: beds, ventilators, nurses and doctors. We apply our analysis to France, Germany and Italy. latter is estimated using average annual occupancy figures. The requirements of each resource are calculated per patient, with multiple data sources used to parameterize the model (Table 1) . [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] There is a one-to-one relationship between patients and beds. On average, only 42% of non-COVID-19 and 68% of COVID-19 patients were estimated to receive mechanical ventilation. 25, 26 Ratios of staff full-time equivalents (FTEs) per occupied bed were informed by recommended staff-to-patient ratios, [27] [28] [29] [30] [31] [32] with maxima of 2.5 ICU beds per nurse and 8 ICU beds per doctor assigned uniformly across countries. Staff availability is reduced using a staffsickness rate to account for the impact of the virus on the workforce. These were calculated for each country using population-infection rates and a modified hazard rate for healthcare workers. This rate remains constant throughout the projection period. Model equations and an illustration of the relationship between bed demand and deficits are provided in the Supplementary Material (Supplementary Figure 1 , available as Supplementary data at IJE online). Baseline national ICU resources were estimated based on pre-pandemic levels. Data were derived from recent official publications from the Ministries of Health and the Organisation for Economic Cooperation and Development (OECD), where available (Table 1) . 15, 18, 20, 22 The baseline occupancy of non-COVID-19 patients was determined using the average annual occupancy of ICU beds. Whereas admissions are often seasonal, this year, it is unclear whether winter increases will occur due to measures to reduce SARS-CoV-2 transmission and reductions in the non-COVID-19 patient care-seeking behaviour due to the pandemic. 34,35 Therefore, figures for the average annual ICU occupancy of non-COVID-19 patients were considered the upper bound for this variable, with alternative scenarios also explored (see the 'Modelled scenarios' section). Epidemiological projections were performed by country using a previously published stochastic compartmental agestructured Susceptible-Exposed-Infected-Recovered model of SARS-CoV-2 transmission. 14 37 For all analyses conducted, the package squire v0.4.34 was used. 38 To tailor the model to capture the dynamics in mortality and ICU demand in each country, the following changes were made to the default model parameters. For France, we used the age-dependent infection fatality ratio (IFR), the probability of hospitalization and the probability of requiring an ICU bed given hospitalization estimated in a previous analysis of the first epidemic wave in France. 39 For Italy, we used the same parameters as for France except that we incorporated a higher IFR as recently estimated from seroprevalence surveys. 40 For Germany, no changes were made to the default model parameters, which sufficiently captured the dynamics in mortality and ICU demand. For all countries, we observed substantial triaging practices to ensure that ICU bed demand did not exceed capacity during the first peak, which we captured in the model by fitting a shorter duration of ICU stay during the first peak. The epidemiological models were assessed according to their fit to both official COVID-19 death data 41 and ICU demand data. 25, 41 Modelled scenarios The calibrated model was used to project ICU demand from COVID-19 patients under different scenarios from 25 October 2020 to 1 March 2021, assuming no substantial impact from potential vaccines in this period. The spare capacity of each resource was then calculated under each of the 100 model simulations for every day of the projection period. COVID-19 ICU demand, and by extension spare capacity, was modelled under an unmitigated (no intervention) scenario and a set of lockdown scenarios in which suppression interventions reduced SARS-CoV-2 transmission, expressed as reductions in the time-varying reproduction number R t . We investigated a trigger-based approach to the initiation of lockdown, implemented when the number of ICU beds required by COVID-19 patients exceeds a proportion of total baseline ICU bed provision (either 1/5, 1/4, 1/3 or 1/2). The length of each triggered lockdown was varied between 2 to 6 weeks and under two levels of suppression. First, it was assumed that subsequent lockdowns were as effective as the initial lockdown of spring 2020 in each country, defined as the lowest R t estimated during this period. Second, given that the reduction in R t likely to be observed in future lockdowns is ambiguous, we also explore a higher R t ¼ 0.8 during lockdowns. This may reflect the lighter suppression measures implemented, weaker adherence to such policies by the population and the emergence of more-transmissible variants of the virus that are more difficult to control. During periods of no lockdown, R t is assumed to return to its estimated value on 25 Taken as the upper bound of this variable. Reductions in the deficit in capacity threshold (30% reduction in these figures to represent cancellation of electives and 0% non-COVID-19 occupancy) were considered in order to account for uncertainty surrounding the demand for care from non-COVID-19 patients this winter (see the 'Modelled scenarios' section). b In the absence of country-specific data, a multiplier to convert headcounts to FTE was derived from the 2017 OECD data sets of 'Physicians employed in hospital' and 'Professional nurses and midwives employed in hospitals' by taking the median multiplier for all Western European countries (0.896 and 0.868, respectively). 33 October 2020. Lastly, we explored the impact of lockdowns being implemented in a non-reactive strategy, instead being introduced at the beginning of November for 2, 4 or 6 weeks before being lifted and re-implemented after 4 or 6 weeks, performed under the same two suppression R t values as above. Estimates of spare capacity over time and maximum deficits are presented as the median and 95% credible intervals (2.5 th and 97.5 th centiles) from the 100 spare capacity curves. Deficits in capacity occur when demand exceeds capacity. Under the baseline parameterization of non-COVID-19 patient ICU occupancy, the deficit threshold is defined by spare capacity falling below zero. Reductions in this threshold, resulting from decreases in non-COVID-19 occupancy, were evaluated in sensitivity analyses. Both a 30% reduction in baseline bed occupancy representing the cancellation of elective surgery 13, 42 and the removal of all non-COVID-19 patients were considered. The latter provides an upper bound on capacity rather than a realistic policy option. These alternative thresholds were calculated by subtracting the number of each resource freed under these occupancy levels from zero (the baseline threshold). Lastly, to characterize the impact of different lockdown triggers and length of lockdowns, we compare the overall mean spare capacity of beds throughout the projection period, the mean number of days with bed deficits and the mean total time spent in lockdown from the same 100 spare capacity curves. Baseline ICU capacity data were publicly available from official government publications, the OECD or academic papers, with the most recent data being from 2017-2018 (Table 1 ). The total number of baseline beds alongside annual average pre-pandemic non-COVID-19 occupancy is illustrated in Figure 1A . The calibrated epidemiological models accurately reproduced patterns of national counts of COVID-19 deaths and At the time of review (January 2021), it was possible to validate our simulated COVID-19 ICU demand against true numbers of COVID-19 patients in intensive care throughout 25 October-31 December 2020 (Supplementary Figure 4 , available as Supplementary data at IJE online). During our simulation period, all three countries implemented NPIs to suppress the transmission of SARS-CoV-2. [2] [3] [4] Consequently, in each country, observed ICU demand falls comfortably within the range of modelled scenarios, with no country following the trajectory of the unmitigated scenario. Our simulations provide an illustration of the impact of possible mitigation scenarios as opposed to providing a prediction of epidemic progression in this period. NPIs are not implemented following an exact trigger threshold as in this study. As such, we hypothesize that differences in the timing and nature of interventions implemented, as well as observed regional variation in demand for ICU resources, 43, 44 explain the small differences between our simulations and that which was observed. For example, in France, simulated peak demand under the largest trigger threshold is of a similar magnitude to that which is observed but occurs later due to lockdown being implemented later in the simulation than in reality, 2 whereas, in Germany, the instigation of national lockdown coincided with the date modelled for the lowest trigger threshold (mid-December), 3 which closely followed the observed demand. Model results of ICU capacity constraints in France, Germany and Italy under no mitigation and different suppression scenarios sustained for 4 weeks when triggered are shown in Figures 2-4 . Across countries, beds were consistently the most constrained resource. Without mitigation of the pandemic, all three countries are estimated to experience substantial shortages of ICU beds over the winter season (Table 2) , with the median maximum deficits corresponding to the same number as the baseline bed capacity in Germany and France and 2.7 times the baseline bed capacity in Italy. In France and Italy, bed deficits were projected to last for almost the entire winter season, peaking in January, whereas, in Germany, they start in around December and continue to grow throughout the projection period. Ventilators reached smaller median maximum deficits of 5000 and 9500 under the unmitigated scenario in France and Germany, respectively. The projections suggest no staff shortages in Germany, in contrast to a median maximum deficit of 941 doctor FTEs in France and 201 doctor FTEs and 2401 nurse FTEs in Italy (Table 2) . However, reduction in baseline occupancy through the cancellation of elective surgery was estimated to be sufficient to restore the positive spare capacity of staff and ventilators (Figures 2-4) . Similarly, with strong suppression measures in the lockdown scenarios, our estimates suggest that these resources generally would not reach a deficit ( Table 2) . The modelled suppression scenarios highlight the large effect that reactive lockdown measures can have on mitigating shortfalls in ICU bed capacity. For a 4-week lockdown as effective as during the first peak, the magnitude and duration of shortages in ICU bed capacity varied across countries and trigger thresholds, but reductions compared with the unmitigated scenario were large throughout ( Table 2 and Figures 2-4) . Depending on the trigger threshold, the lockdown scenario reduced the median maximum bed deficits by between 56-89% and 65-96%, and reduced the median duration of deficits by between 33-65% and 30-81% in France and Germany, respectively. In Italy, reactive lockdowns only resulted in deficits in beds for the highest ICU trigger threshold. Under the 1/2 ICU capacity trigger threshold lockdown scenario, remaining median maximum deficits of 4741, 10 805 and 889 beds (representing 45%, 38% and 17% of baseline bed capacity) in France, Germany and Italy, respectively, were estimated to be prevented by additional reductions in baseline ICU occupancy through the cancellation of elective surgery on average (Figures 2-4) . The impact of and total time spent under a reactive lockdown were compared under different assumptions of trigger thresholds, lockdown duration and effectiveness. Spare ICU bed capacity varied substantially between scenarios using the highest and lowest lockdown trigger thresholds. In France and Germany, the highest trigger threshold resulted in increases of three and nine times the maximum deficits under the lowest thresholds, respectively (Table 2) , and the lowest trigger threshold consistently resulted in the shortest time with a shortage of beds ( Figure 5 ). In Italy, the lowest trigger threshold similarly resulted in the largest median spare ICU bed capacity over the projection period and bed deficits were prevented altogether under all but the 1/2 ICU capacity threshold. This difference between countries is largely explained by the substantially lower baseline occupancy of ICU beds in Italy by non-COVID patients (48%) compared with France (87%) and Germany (79%) ( Figure 1A) . The lower baseline occupancy affords reactive strategies more time for the impact of lockdown measures to have an effect before reaching capacity limits. Altering the length of each lockdown by between 2 and 6 weeks resulted in minimal reductions in the maximum deficits under equivalent scenarios (Supplementary Figures 5-10 and Supplementary Tables 2-3, available as Supplementary data at IJE online). This is largely due to lockdowns needing to be implemented immediately in the scenarios with the lowest ICU trigger thresholds, reflecting that ICU demand was already high at the beginning of the projection period. However, the average spare ICU bed capacity tended to increase with lockdown length, notably in France, whereas the relationship between lockdown length and number of days in deficits varied by country. In Germany, the number of days of bed deficits are not dependent on lockdown length due to the particularly low level of R t achieved during the first lockdown ( Figures 1B and 5) . A lockdown sustained at a lower level of suppression also resulted in only small increases in the maximum bed deficits compared with the stronger lockdown for a given trigger threshold (Table 2) , except for in Germany, where The total time spent in lockdown in France and Italy over the projection period increases slightly under lower trigger thresholds ( Figure 5 ). In Germany, the effectiveness of the first lockdown results in a similar amount of time in lockdown under different trigger thresholds. In Italy, the similarity in the 2and 4-week lockdown length scenarios reflects that successive lockdowns are quickly implemented in the 2-week lockdown scenario, with a 2-week lockdown unable to reduce transmission enough to reduce demand below the ICU trigger threshold. The comparatively lower assumed total ICU capacity in Italy (5200 beds) compared with France (10 640 beds) and Germany (28 403 beds) also resulted in more frequent lockdowns being implemented in Italy, with almost 6 weeks predicted to be spent in lockdown before 1 March. Lockdowns of pre-determined fixed start and end dates were generally estimated to have a similar effect on reducing deficits, but with small increases in the total amount of time spent in lockdown ( Supplementary Figures 12-14 , available as Supplementary data at IJE online). In this study, we examined potential constraints of four key ICU resources in France, Germany and Italy under different epidemic scenarios over the winter of 2020-2021. The unmitigated scenarios resulted in COVID-19 ICU patient numbers exceeding those seen in the first peak, thus inducing capacity deficits. Triggered lockdown scenarios substantially reduced these deficits. Our study found that, across all epidemic scenarios, beds are consistently the most constrained ICU resource. Projections of constraints in doctors, nurses and ventilators varied across countries, but were found to be manageable through the implementation of lockdowns, as well through reductions in baseline bed occupancy, e.g. via the cancellation of elective surgery. The results suggest that lockdowns triggered based on ICU occupancy could lead to large increases in spare bed capacity during the winter compared with no intervention, reducing deficits in all countries to lower levels that can then be managed by hospital provision interventions. Lower trigger thresholds generally minimize deficits by implementing lockdowns earlier, but their impact is dependent on baseline ICU bed numbers and average non-COVID-19 patient occupancy. For example, Italy, with a lower average occupancy, can accommodate greater demand from COVID-19 patients relative to the total ICU bed capacity. For a given trigger threshold, increasing the length of lockdown only provides small decreases in the number of days in deficits. On the other hand, a lockdown less effective than the first peak reduces deficits compared with the unmitigated scenario but could also lead to an increase in the amount of time spent in lockdown and the requirement of a lower trigger threshold compared with a stronger lockdown. Our results highlight the dependencies between these metrics, suggesting that absolute benefits of different strategies must be weighed against the feasibility and drawbacks of an increased amount of time spent in lockdown. Our study integrates two critical frameworks of significance in the control of the pandemic: hospital capacity estimation and epidemiological simulations. Whereas previous studies have used epidemiological modelling to project ICU demand, data on hospital capacity failed to consider key ICU resources other than beds and the dependencies between them. 12 Further strengths of this study include the use of a dual-demand model considering changes in demand for ICU care of both COVID-19 and non-COVID-19 patients, and the incorporation of COVID-19-related staff sickness that has shown to result in substantial additional constraints. 45 Though countries have differing definitions of intensive care, our results also provide insights into how requirements for ICU capacity management may vary between countries with different healthcare systems and epidemic trajectories. Specifically, this allows policymakers to consider how to combine interventions to alleviate strain on hospital capacity effectively via the use of NPIs, by reducing the number of non-COVID-19 patients and increasing ICU capacity through the use of supply-side provision interventions (see Supplementary Material, available as Supplementary data at IJE online, for further discussion). There are some limitations of this study. First, data were sometimes missing or of low quality. Due to poor documentation at the national level, it was not possible to quantify the expansion of hospital capacity during the first peak of COVID-19 patients. Capacity deficits may be overestimated, although many of the implemented hospital provision interventions were temporary. Data from the first peaks in spring 2020 used to parameterize the model, e.g. ventilation requirements, may have changed due to changes in clinical practice. For example, the use of dexamethasone for treating individuals receiving oxygen has been shown to decrease COVID-19 mortality. 46 Data on the use of dexamethasone over time in each country are lacking; the resultant reduction of IFR would lead to an increased ICU demand in order to reproduce the observed mortality. This could be the explanation for our slight underestimation of ICU demand at the beginning of the second wave ( Supplementary Figures 2 and 4 , available as Supplementary data at IJE online). Second, modelled estimates of the spare capacity of nurses and doctors are likely to be uncertain as ward-based bed-to-staff ratios have previously been shown to be inconsistent in approximating national staffing requirements 47, 48 and there is no single recommended methodological standard for staff ratios across the countries. 49 However, our unmitigated scenario results broadly align with a recent study analysing healthcare pressure in Europe due to the COVID-19 pandemic. 50 Third, the model does not account for cohorting of COVID-19 and non-COVID-19 patients within hospitals, which likely reduces available resources, but this will vary between hospitals and is beyond the scope of this analysis. Fourth, whereas R t may not remain constant during lockdown periods, we made this simplifying assumption to avoid having a confusing number of alternative scenarios. This means that we did not account for the emergence of more-transmissible variants of SARS-CoV-2 during the simulation period, which may increase pressure on health services despite implemented lockdown measures. However, our scenarios broadly encompass true COVID-19 ICU demand within each country in November and December 2020 (Supplementary Figure 4 , available as Supplementary data at IJE online). Fifth, the comparison between different lockdown triggers and lengths is limited by having a fixed end date for comparison (1 March 2021) . Consequently, the timing of lockdowns within this evaluation period leads to non-monotonic relationship between lockdown length and the spare capacity of ICU beds. Lastly, we do not consider the impact of vaccines. COVID-19 vaccines were approved for use across Europe in December 2020. 51 However, over the time period that we consider, vaccination will have a very small effect, due to the time taken for a significant proportion to receive the vaccine and then develop immune protection. While the trajectory of the COVID-19 pandemic over winter is unknown, our findings suggest that a combination of strategies will be required to overcome potential ICU capacity deficits and ensure the treatment of all patients, regardless of COVID-19 status, in France, Germany and Italy. Although this analysis focused on these three countries, similar questions surrounding the required winter interventions must now be answered across Europe, with substantial second waves being observed across the continent, which have eclipsed the first wave in several countries. The large trade-offs inherent in each strategy should not be underestimated and continuous decisionmaking by national policymakers will be required across the winter period 2020-2021. Supplementary Data are available at IJE online. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in COVID-19 Health Policy Response Monitor: Policy responses for France. COVID-19 Health System Response Monitor COVID-19 Health Policy Response Monitor: Policy Responses for Germany Health System Response Monitor COVID-19 Health Policy Response Monitor: Policy Responses for Italy: COVID-19 Health System Response Monitor Vulnerability to winter mortality in elderly people in Britain: population based study Se préparer maintenant pour anticiper un retour du virus à l'automne Elementi di preparazione e risposta a COVID-19 nella stagione autunnoinvernale Preparing for a Challenging Winter Projecting hospital utilization during the COVID-19 outbreaks in the United States Projecting demand for critical care beds during COVID-19 outbreaks in Canada COVID-19 healthcare demand and mortality in Sweden in response to nonpharmaceutical mitigation and suppression scenarios The J-IDEA pandemic planner: a framework for implementing hospital provision interventions during the COVID-19 pandemic Adapting hospital capacity to meet changing demands during the COVID-19 pandemic The impact of COVID-19 and strategies for mitigation and suppression in lowand middle-income countries Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study Aktueller Lage-/Situationsbericht des RKI zu COVID-19 A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units SDO/ 2003/413 du 27 aoû t 2003 rela tive aux établissements de santé publics et privés pratiquant la réanimation, les soins intensifs et la surveillance continue Publikationen Empfehlungen der DIVI im Überblick Respiratory intensive care units in Italy: a national census and prospective cohort study The Faculty of Intensive Care Medicine. Core Standards for Intensive Care Units The Faculty of Intensive Care Medicine. Guidelines for the Provision of Intensive Care Services Intensive Care Beds Capacity Statistique Annuelle Des É tablissements De Santé Grunddaten der Krankenhäuser Annuario Statistico del Servizio Sanitario Nazionale Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study Covid-19: French sidelining of patient associations is a global trend Imperial College COVID-19 LMIC Reports Estimating the burden of COVID-19 in Damascus, Syria: an analysis of novel data sources to infer mortality under-ascertainment Estimating the burden of SARS-CoV-2 in France COVID-19 infection fatality ratio: estimates from seroprevalence Publications & Data. 2020 Trends from the London Trusts about Whether Their Medical/Surgical and other Specialty Admissions Have Increased as the Outbreak Has Developed Covid-19: découvrez le taux d'occupation en réanimation dans les hô pitaux de votre département Rapporto Covid-19 Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. 2020 World Population Prospects Démographie et structures des services de réanimation franc¸ais (hors réanimation chirurgicale): état des lieux Synthèse statistique: Recensement des respirateurs, lits et effectifs en unités de réanimation, unités de surveillance continue et salles de soins post-opératoires Personalsituation in der Intensivpflege und Intensivmedizin Potential association between COVID-19 mortality and health-care resource availability Dexamethasone in hospitalized patients with COVID-19 How many nurses per patient? measurements of nurse staffing in health services research: how many nurses per patient? Nursing workload, nurse staffing methodologies and tools: a systematic scoping review and discussion The effect of nurse-topatient ratios on nurse-sensitive patient outcomes in acute specialist units: a systematic review and meta-analysis Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases European Centre for Disease Prevention and Control. COVID-19 Vaccination and Prioritisation Strategies in the EU/EEA. 2020 The views expressed are those of the authors and not necessarily those of the United Kingdom (UK) Department of Health and Social Care, EU, FCDO, MRC, National Health Service, NIHR or PHE. The funding bodies had no role in the design of the study, analysis and interpretation of data and in writing the manuscript. No ethics approval was required for this study, as this research is not based on human subjects. Much of the data underlying this article are available in the article and in its online Supplementary Material. Data from COVID-19 models and simulations are available at https://github.com/j-idea/eu rope-icu-capacity. None declared.